Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03471481 · ClinicalTrials.gov registry record
Magnesium as a Mediator of Bone and Vitamin D Metabolism in Patients on Antiepileptic Drug Therapy
A clinical trial, sponsored by Drexel University.
- Terminated
- Registry status
- 7
- Enrollment target
NCT03471481 is a clinical trial that was terminated before completion, run by Drexel University. The registered enrollment target is 7 participants.
The verdict
NCT03471481 was terminated before completion, sponsored by Drexel University.
- TERMINATED
- Registry status
- 7 participants
- Enrollment target
Study Summary
The objective of this study is to determine the role of magnesium on bone and vitamin D metabolism in patients receiving anti-epileptic medications.
Interventions
- OTHER No Intervention. Study is Cross Sectional in nature
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2015-08-10 |
| Est. Completion | 2019-08-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03471481
The ClinicalTrials.gov registry entry for NCT03471481 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Drexel University, which has 92 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No Intervention. Study is Cross Sectional in nature is the first listed.
NCT03471481 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03471481 about?
NCT03471481 is a clinical study titled "Magnesium as a Mediator of Bone and Vitamin D Metabolism in Patients on Antiepileptic Drug Therapy". The objective of this study is to determine the role of magnesium on bone and vitamin D metabolism in patients receiving anti-epileptic medications.
What is the current status of trial NCT03471481?
This trial is currently terminated. The enrollment target is 7 participants. The study started on 2015-08-10. Estimated completion is 2019-08-01.
What interventions are being tested in trial NCT03471481?
The interventions under investigation include: No Intervention. Study is Cross Sectional in nature (OTHER).
Who is sponsoring clinical trial NCT03471481?
This trial is sponsored by Drexel University, which has 92 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.